Delivery Order SPE2DB22D3501-SPE2DB25FUN20
- Not listed
- The Defense Logistics Agency awarded a $17,544.13 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens. This is a firm fixed price contract with an ultimate completion date of August 25, 2025, and represents a non-set-aside, competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under...
- The Defense Logistics Agency awarded a $3,050.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens. The order is scheduled for completion by September 2, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $17,573.28 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pens on August 20, 2025, with completion scheduled for August 21, 2025. This competitive award, issued under a firm fixed-price delivery order contract, represents a single transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $10,016.78 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections. This firm fixed price contract, with an ultimate completion date of September 8, 2025, represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $18,845.38 for Zepbound 2.5 mg/0.5 mL pens on June 2, 2025, with completion scheduled for June 3, 2025. This firm fixed-price contract, executed without set-aside designation, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Zepbound 10 mg/0.5 mL pens valued at $7,637.15 with a completion date of June 18, 2025. This non-competitive delivery order utilizes firm fixed price pricing and represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Zepbound 5 mg/0.5 ml pens valued at $1,553.39. This is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, performed at the contractor's location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $19,626.65 to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Zepbound 10 mg/0.5 mL pens. The contract carries a firm fixed price structure with no set-aside designation and an ultimate completion date of September 3, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $8,145.69 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections. The contract, which was competitively awarded without set-aside restrictions, is scheduled for completion by August 8, 2025, and will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $3,292.56 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors with an ultimate completion date of August 19, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded under an open procurement process. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FUN20Delivery Order
The Defense Logistics Agency awarded a $2,287.74 delivery order to AmerisourceBergen Drug Corp on February 11, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens. The contract is classified as firm fixed price with no set-aside designation, indicating it was awarded through open competition. Performance will be completed by February 12, 2025, at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. The company's extensive federal contract portfolio encompasses a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. This Zepbound delivery order reflects the company's ongoing role in supplying pharmaceutical products to support defense healthcare operations and federal medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 2/11/25 |